Skip to content
healthcare.dev

Lisdexamfetamine Dimesylate

NDC 0527-4664, Lisdexamfetamine Dimesylate, capsule, from Lannett Company, LLC.

Product NDC
0527-4664
Status
Listed
Labeler
Lannett Company, LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215802
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0527-4664 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LISDEXAMFETAMINE DIMESYLATE40 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
0527-4664-3700527466437100 CAPSULE in 1 BOTTLE (0527-4664-37)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2cedb4c2-1e40-4bc4-b9f4-127150c4afbd
  • NADAC price for package 00527466437

    GET /v1/drugs/nadac/00527466437

Use it

Look up 0527-4664 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0527-4664 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0527-4664. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.